Title: RESTORE Act of 2019
Policy area: Crime and Law Enforcement

Summary:
Restoring Enforcement Standards to Track Opioids Responsively and Effectively Act of 2019 or the RESTORE Act of 2019
This bill repeals the Ensuring Patient Access and Effective Drug Enforcement Act of 2016. That act modified the standards that the Drug Enforcement Administration must apply when deciding whether to deny, revoke, or suspend the registration of a manufacturer, distributor, or dispenser of controlled substances (i.e., substances regulated under federal law based on their medical use and potential for dependence and abuse).

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4563 Introduced in House (IH)]

<DOC>






116th CONGRESS
  1st Session
                                H. R. 4563

   To repeal Public Law 114-145 to ensure that the Drug Enforcement 
   Administration has the authority to carry out needed enforcement 
  actions for drug diversion control investigations and operations to 
          combat the opioid epidemic, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           September 27, 2019

     Mr. Fitzpatrick (for himself and Ms. Kuster of New Hampshire) 
 introduced the following bill; which was referred to the Committee on 
Energy and Commerce, and in addition to the Committee on the Judiciary, 
for a period to be subsequently determined by the Speaker, in each case 
for consideration of such provisions as fall within the jurisdiction of 
                        the committee concerned

_______________________________________________________________________

                                 A BILL


 
   To repeal Public Law 114-145 to ensure that the Drug Enforcement 
   Administration has the authority to carry out needed enforcement 
  actions for drug diversion control investigations and operations to 
          combat the opioid epidemic, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Restoring Enforcement Standards to 
Track Opioids Responsively and Effectively Act of 2019'' or the 
``RESTORE Act of 2019''.

SEC. 2. RESTORING DEA'S AUTHORITY TO CARRY OUT NEEDED ENFORCEMENT 
              ACTIONS TO COMBAT DRUG DIVERSION AND THE OPIOID EPIDEMIC.

    (a) Repeal.--Public Law 114-145 (the Ensuring Patient Access and 
Effective Drug Enforcement Act of 2016) is hereby repealed.
    (b) Restoration of Provisions.--
            (1) Effective as of the date of enactment of Public Law 
        114-145, the provisions of section 304 of the Controlled 
        Substances Act (21 U.S.C. 824) that were amended by Public Law 
        114-145 are hereby restored as if Public Law 114-145 had not 
        been enacted into law.
            (2) Subsection (k) of section 303 of the Controlled 
        Substances Act (21 U.S.C. 823(k)), as added by Public Law 114-
        145 and redesignated by Public Law 115-83, is hereby repealed.
                                 <all>